Παρασκευή 16 Μαρτίου 2018

The use of EGFR-CD3 bispecific antibody and antigen-specific high avidity T cells to target cancer associated fibroblasts and cancer cells within a melanoma organoid system

alertIcon.gif

Publication date: March 2018
Source:European Journal of Cancer, Volume 92, Supplement 1
Author(s): N. Reddy, B. Chung, E. Chu, A. Esmaeili, T. Tu, P. Lee




from Cancer via ola Kala on Inoreader http://ift.tt/2pkJhKi
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου